Cargando…

Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting

BACKGROUND: Given the high prevalence of cognitive impairment in Parkinson’s disease (PD), cognitive screening is important in clinical practice. The Montreal Cognitive Assessment (MoCA) is a frequently used screening test in PD to detect mild cognitive impairment (PD-MCI) and Parkinson’s disease de...

Descripción completa

Detalles Bibliográficos
Autores principales: Fengler, Sophie, Kessler, Josef, Timmermann, Lars, Zapf, Alexandra, Elben, Saskia, Wojtecki, Lars, Tucha, Oliver, Kalbe, Elke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954721/
https://www.ncbi.nlm.nih.gov/pubmed/27437705
http://dx.doi.org/10.1371/journal.pone.0159318
_version_ 1782443819916066816
author Fengler, Sophie
Kessler, Josef
Timmermann, Lars
Zapf, Alexandra
Elben, Saskia
Wojtecki, Lars
Tucha, Oliver
Kalbe, Elke
author_facet Fengler, Sophie
Kessler, Josef
Timmermann, Lars
Zapf, Alexandra
Elben, Saskia
Wojtecki, Lars
Tucha, Oliver
Kalbe, Elke
author_sort Fengler, Sophie
collection PubMed
description BACKGROUND: Given the high prevalence of cognitive impairment in Parkinson’s disease (PD), cognitive screening is important in clinical practice. The Montreal Cognitive Assessment (MoCA) is a frequently used screening test in PD to detect mild cognitive impairment (PD-MCI) and Parkinson’s disease dementia (PD-D). However, the proportion in which the subtests are represented in the MoCA total score does not seem reasonable. We present the development and preliminary evaluation of an empirically based alternative scoring system of the MoCA which aims at increasing the overall diagnostic accuracy. METHODS: In study 1, the MoCA was administered to 40 patients with PD without cognitive impairment (PD-N), PD-MCI, or PD-D, as defined by a comprehensive neuropsychological test battery. The new MoCA scoring algorithm was developed by defining Areas under the Curve (AUC) for MoCA subtests in a Receiver Operating Characteristic (ROC) and by weighting the subtests according to their sensitivities and specificities. In study 2, an independent sample of 24 PD patients (PD-N, PD-MCI, or PD-D) was tested with the MoCA. In both studies, diagnostic accuracy of the original and the new scoring procedure was calculated. RESULTS: Diagnostic accuracy increased with the new MoCA scoring algorithm. In study 1, the sensitivity to detect cognitive impairment increased from 62.5% to 92%, while specificity decreased only slightly from 77.7% to 73%; in study 2, sensitivity increased from 68.8% to 81.3%, while specificity stayed stable at 75%. CONCLUSION: This pilot study demonstrates that the sensitivity of the MoCA can be enhanced substantially by an empirically based weighting procedure and that the proposed scoring algorithm may serve the MoCA’s actual purpose as a screening tool in the detection of cognitive dysfunction in PD patients better than the original scoring of the MoCA. Further research with larger sample sizes is necessary to establish efficacy of the alternate scoring system.
format Online
Article
Text
id pubmed-4954721
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49547212016-08-08 Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting Fengler, Sophie Kessler, Josef Timmermann, Lars Zapf, Alexandra Elben, Saskia Wojtecki, Lars Tucha, Oliver Kalbe, Elke PLoS One Research Article BACKGROUND: Given the high prevalence of cognitive impairment in Parkinson’s disease (PD), cognitive screening is important in clinical practice. The Montreal Cognitive Assessment (MoCA) is a frequently used screening test in PD to detect mild cognitive impairment (PD-MCI) and Parkinson’s disease dementia (PD-D). However, the proportion in which the subtests are represented in the MoCA total score does not seem reasonable. We present the development and preliminary evaluation of an empirically based alternative scoring system of the MoCA which aims at increasing the overall diagnostic accuracy. METHODS: In study 1, the MoCA was administered to 40 patients with PD without cognitive impairment (PD-N), PD-MCI, or PD-D, as defined by a comprehensive neuropsychological test battery. The new MoCA scoring algorithm was developed by defining Areas under the Curve (AUC) for MoCA subtests in a Receiver Operating Characteristic (ROC) and by weighting the subtests according to their sensitivities and specificities. In study 2, an independent sample of 24 PD patients (PD-N, PD-MCI, or PD-D) was tested with the MoCA. In both studies, diagnostic accuracy of the original and the new scoring procedure was calculated. RESULTS: Diagnostic accuracy increased with the new MoCA scoring algorithm. In study 1, the sensitivity to detect cognitive impairment increased from 62.5% to 92%, while specificity decreased only slightly from 77.7% to 73%; in study 2, sensitivity increased from 68.8% to 81.3%, while specificity stayed stable at 75%. CONCLUSION: This pilot study demonstrates that the sensitivity of the MoCA can be enhanced substantially by an empirically based weighting procedure and that the proposed scoring algorithm may serve the MoCA’s actual purpose as a screening tool in the detection of cognitive dysfunction in PD patients better than the original scoring of the MoCA. Further research with larger sample sizes is necessary to establish efficacy of the alternate scoring system. Public Library of Science 2016-07-20 /pmc/articles/PMC4954721/ /pubmed/27437705 http://dx.doi.org/10.1371/journal.pone.0159318 Text en © 2016 Fengler et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Fengler, Sophie
Kessler, Josef
Timmermann, Lars
Zapf, Alexandra
Elben, Saskia
Wojtecki, Lars
Tucha, Oliver
Kalbe, Elke
Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting
title Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting
title_full Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting
title_fullStr Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting
title_full_unstemmed Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting
title_short Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting
title_sort screening for cognitive impairment in parkinson's disease: improving the diagnostic utility of the moca through subtest weighting
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954721/
https://www.ncbi.nlm.nih.gov/pubmed/27437705
http://dx.doi.org/10.1371/journal.pone.0159318
work_keys_str_mv AT fenglersophie screeningforcognitiveimpairmentinparkinsonsdiseaseimprovingthediagnosticutilityofthemocathroughsubtestweighting
AT kesslerjosef screeningforcognitiveimpairmentinparkinsonsdiseaseimprovingthediagnosticutilityofthemocathroughsubtestweighting
AT timmermannlars screeningforcognitiveimpairmentinparkinsonsdiseaseimprovingthediagnosticutilityofthemocathroughsubtestweighting
AT zapfalexandra screeningforcognitiveimpairmentinparkinsonsdiseaseimprovingthediagnosticutilityofthemocathroughsubtestweighting
AT elbensaskia screeningforcognitiveimpairmentinparkinsonsdiseaseimprovingthediagnosticutilityofthemocathroughsubtestweighting
AT wojteckilars screeningforcognitiveimpairmentinparkinsonsdiseaseimprovingthediagnosticutilityofthemocathroughsubtestweighting
AT tuchaoliver screeningforcognitiveimpairmentinparkinsonsdiseaseimprovingthediagnosticutilityofthemocathroughsubtestweighting
AT kalbeelke screeningforcognitiveimpairmentinparkinsonsdiseaseimprovingthediagnosticutilityofthemocathroughsubtestweighting